In the age of COVID-19, the opioid epidemic has taken a sharp turn for the worse. According to provisional data released by the CDC, drug overdose deaths in the U.S. rose by nearly 30 percent in 2020 ‒ the largest single-year increase ever recorded.
Between isolated lockdowns, economic devastation, and unprecedented times of uncertainty, overdose deaths surged. And consequences of both the COVID-19 and overdose crises have hit vulnerable populations particularly hard. Ranging from Black, Brown, and rural communities to the growing patient populations throughout the prison system, disrupted and unequal access to addiction support and treatment continues to persist.
As we continue to combat our nation’s opioid epidemic, how should we be addressing disparities in addiction treatment and provide Americans the help they need? What changes can be made to the way the criminal justice system responds to opioid use disorder? How can leaders put in place solutions that tackle these issues and the stigma surrounding them?
Tuesday, September 21, 2021 1:00 PM ET / 10:00 AM PT
Rep. Lisa Blunt Rochester (D-DE), Member, Committee on Energy & Commerce; Member, Bipartisan Heroin Task Force Edwin C. Chapman, MD, Specialist, Internal Medicine & Addiction Medicine Mark Parrino, President, American Association for the Treatment of Opioid Dependence Rep. Mike Turner (R-OH), Member, Addiction, Treatment, & Recovery Caucus Dr. Tisha Wiley, Chief of the Services Research Branch & Associate Director for Justice Systems, National Institute on Drug Abuse
Additional speakers to be announced.
Christian Heidbreder, Chief Scientific Officer, Indivior
Steve Clemons, Editor-at-Large, The Hill